about
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.Elevated malondialdehyde levels in sepsis - something to 'stress' about?Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis.Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shockThe temporal version of the pediatric sepsis biomarker risk model.Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding ProteinIdentifying Pediatric Severe Sepsis and Septic Shock: Accuracy of Diagnosis Codes.A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock.Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study.Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability.Protocolized Treatment Is Associated With Decreased Organ Dysfunction in Pediatric Severe Sepsis.The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die.Improving Recognition of Pediatric Severe Sepsis in the Emergency Department: Contributions of a Vital Sign-Based Electronic Alert and Bedside Clinician Identification.Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children.Are septic children really just "septic little adults"?Major Adverse Kidney Events in Pediatric SepsisProspective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk ModelRisks and benefits of fluid bolus therapy: the need for a good explanationIs chloride worth its salt?
P50
Q33738328-6D64DAB0-CC58-4830-B123-3339214AAF5AQ33752785-03A59F45-7B46-4E49-B204-5CB02BB54175Q33901670-5CFFF447-919D-4E26-85CE-1563305510CDQ34490041-C20BA89C-3B1B-483E-9664-2129F84EA388Q34587242-E66D866B-0AEF-4DCA-8964-1A2C0918DEA2Q35120147-94E659FD-E28F-47CB-814E-E13213B27424Q35992557-3FEF1643-BBEA-4789-B0BC-9043E2140D25Q36327690-B64AA41E-6C28-4313-925B-ECA6A9140DA7Q36341842-00121B28-27A9-45F4-8738-ACA3B6276965Q38783264-30C5EEA2-4297-4D76-80FF-9E352B213E37Q39034299-D793542F-408F-40BE-A01D-CC7BF072D7C5Q39500397-C00EEC63-B672-4790-A346-A51B5677A10DQ39562884-9DC6FF25-2AB7-43A5-BCD2-63F24D454D52Q40183960-1C190025-83EE-415F-B4D8-430CE6369E4BQ40184544-D1A3DFF8-5BDB-438F-AA7E-4E7AF6B57569Q40402027-CC7ABCAE-56AF-4D5E-A0C2-24D20A86C4EDQ54257844-28794297-D793-403F-A792-477D0B19D867Q54284110-641833F6-DB70-440D-A802-5C65A0AF3218Q89996431-6B48C9D0-D834-45E1-BED8-3ABAA062364AQ91271927-726C616B-02BA-49EA-A792-4D2520D9CEADQ92831266-8DEB6268-4D2D-45EF-B792-C7D311C9FF30Q93384823-700DF49C-C325-4F38-B1B1-8DD3E2986552
P50
description
researcher
@en
name
Scott L Weiss
@en
type
label
Scott L Weiss
@en
prefLabel
Scott L Weiss
@en
P31
P496
0000-0002-7040-3281